Table 35.
N (%)a | |
---|---|
N-Acetylcysteine | 974 (27.5) |
Naloxone/nalmefene | 705 (19.9) |
Sodium bicarbonate | 421 (11.9) |
Thiamine | 250 (7.1) |
Folate | 201 (5.7) |
Physostigmine | 147 (4.2) |
Fomepizole | 119 (3.4) |
Calcium | 110 (3.1) |
Glucagon | 98 (2.8) |
Flumazenil | 63 (1.8) |
Cyproheptadine | 58 (1.6) |
Vitamin K | 51 (1.4) |
Atropine | 47 (1.3) |
L-Carnitine | 44 (1.3) |
Insulin-euglycemic therapy | 44 (1.3) |
Octreotide | 44 (1.3) |
Fab for digoxin | 34 (1.0) |
Lipid resuscitation | 25 (0.8) |
Pyridoxine | 26 (0.7) |
Hydroxocobalamin | 17 (0.5) |
Methylene blue | 14 (0.4) |
Dantrolene | 9 (0.3) |
2-PAM | 7 (0.2) |
Bromocriptine | 6 (0.2) |
Thiosulfate | 6 (0.2) |
Anticoagulation reversal | 5 (0.1) |
Botulinum antitoxin | 3 (0.1) |
Ethanol | 2 (0.1) |
Nitrites | 2 (0.1) |
Coagulation factor replacement | 1 (<0.1) |
Protamine | 1 (<0.1) |
Total | 3540 (100) |
aPercentages are out of the total number of antidotes administered (N = 3540); 3047 cases (35.7% of total Registry cases) received at least one antidote; some cases involve multiple antidotes